Schechter, 2005, Innovative approaches for the development of antidepressant drugs: current and future strategies, NeuroRx, 2, 590, 10.1602/neurorx.2.4.590
Spitzer, 1994
Mathers, 2008
Pariante, 2008, The HPA axis in major depression: classical theories and new developments, Trends Neurosci, 31, 464, 10.1016/j.tins.2008.06.006
Zunszain, 2011, Glucocorticoids, cytokines and brain abnormalities in depression, Prog Neuropsychopharmacol Biol Psychiatry, 35, 722, 10.1016/j.pnpbp.2010.04.011
Johnson, 2006, Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor, Behav Brain Res, 168, 280, 10.1016/j.bbr.2005.11.019
Dwivedi, 2006, Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone, Neuroscience, 139, 1017, 10.1016/j.neuroscience.2005.12.058
Zhao, 2008, A mouse model of depression induced by repeated corticosterone injections, Eur J Pharmacol, 581, 113, 10.1016/j.ejphar.2007.12.005
Gregus, 2005, Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats, Behav Brain Res, 156, 105, 10.1016/j.bbr.2004.05.013
Shen, 2007, Advances in research on biological etiology of depression and the antidepressants, Pharm Care Res, 7, 94
Kirsch, 2008, Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration, PLoS Med, 5, e45, 10.1371/journal.pmed.0050045
Maruyama, 2000, Overview of the pharmacological features of honokiol, CNS Drug Rev, 6, 35, 10.1111/j.1527-3458.2000.tb00136.x
Liu, 2008, Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer, Eur J Pharmacol, 591, 43, 10.1016/j.ejphar.2008.06.026
Xu, 2008, Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents, Prog Neuropsychopharmacol Biol Psychiatry, 32, 715, 10.1016/j.pnpbp.2007.11.020
Huston, 2009, Toward an animal model of extinction-induced despair: focus on aging and physiological indices, J Neural Transm, 116, 1029, 10.1007/s00702-009-0210-4
Ibarguen-Vargas, 2009, Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress, Behav Brain Res, 202, 245, 10.1016/j.bbr.2009.03.040
Huang, 2011, Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats, Neurosci Lett, 493, 145, 10.1016/j.neulet.2011.02.030
Wu, 2012, Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior, Psychoneuroendocrinology
Kuribara, 2000, Comparative assessment of the anxiolytic-like activities of honokiol and derivatives, Pharmacol Biochem Behav, 67, 597, 10.1016/S0091-3057(00)00401-9
Mao, 2009, Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic–pituitary–adrenal function and brain-derived neurotrophic factor, Prog Neuropsychopharmacol Biol Psychiatry, 33, 1211, 10.1016/j.pnpbp.2009.07.002
Porsolt, 1977, Behavioral despair in mice: a primary screening test for antidepressants, Arch Int Pharmacodyn Ther, 229, 327
Parasuraman, 2010, Blood sample collection in small laboratory animals, J Pharmacol Pharmacother, 1, 87, 10.4103/0976-500X.72350
Brunoni, 2008, A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression, Int J Neuropsychopharmacol, 11, 1169, 10.1017/S1461145708009309
Karege, 2002, Decreased serum brain-derived neurotrophic factor levels in major depressed patients, Psychiatry Res, 109, 143, 10.1016/S0165-1781(02)00005-7
Shimizu, 2003, Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants, Biol Psychiatry, 54, 70, 10.1016/S0006-3223(03)00181-1